Comparison of root canal debridement using hand, sonic, and ultrasonic techniques.

E. S. Kaminsky,C. Newton,C. E. Brown

IF: 2.5

Journal

Abstract:

What problem does this paper attempt to address?

AI in Pathology: What could possibly go wrong?

Keisuke Nakagawa,Lama Moukheiber,Malhar Patel,Faisal Mahmood,Dibson Gondim,Michael Hogarth,Richard Levenson,Leo Celi

DOI: https://doi.org/10.1053/j.semdp.2023.02.006

IF: 3.893

2023-03-03

Seminars in Diagnostic Pathology

Abstract:The field of medicine is undergoing rapid digital transformation. Pathologists are now striving to digitize their data, workflows, and interpretations, assisted by the enabling development of whole-slide imaging. Going digital means that the analog process of human diagnosis can be augmented or even replaced by rapidly evolving AI approaches, which are just now entering into clinical practice. But with such progress comes challenges that reflect a variety of stressors, including the impact of unrepresentative training data with accompanying implicit bias, data privacy concerns, and fragility of algorithm performance. Beyond such core digital aspects, considerations arise related to difficulties presented by changing disease presentations, diagnostic approaches, and therapeutic options. While some tools such as data federation can help with broadening data diversity while preserving expertise and local control, they may not be the full answer to some of these issues. The impact of AI in pathology on the field's human practitioners is still very much unknown: installation of unconscious bias and deference to AI guidance need to be understood and addressed. If AI is widely adopted, it may remove many inefficiencies in daily practice and compensate for staff shortages. It may also cause practitioner deskilling, dethrilling, and burnout. We discuss the technological, clinical, legal, and sociological factors that will influence the adoption of AI in pathology, and its eventual impact for good or ill.

pathology,medical laboratory technology
Shelf-stable and safe intermediate-moisture meat products using hurdle technology.

Sweetie R. Kanatt,S. P. Chawla,R. Chander,D. Bongirwar

DOI: https://doi.org/10.4315/0362-028X-65.10.1628

IF: 2.745

2002-10-01

Journal of Food Protection

Abstract:A number of ready-to-use shelf-stable intermediate-moisture (IM) spiced mutton and spiced chicken products were developed with a combination of hurdles (reduced moisture, vacuum packing, and irradiation). The water activity of the products was reduced to about 0.80 either by grilling or by hot-air drying. These IM products were vacuum packed and subjected to gamma radiation processing at 0 to 10 kGy. Microbiological analyses revealed a radiation dose-dependent reduction in total viable counts and in numbers of Staphylococcus species. IM meat products that did not undergo radiation treatment showed visible mold growth within 2 months. The products subjected to irradiation at 10 kGy showed an absence of viable microorganisms and also retained high sensory acceptability for up to 9 months at ambient temperatures.
Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling

Albrecht Stenzinger,Maximilian Alber,Michael Allgäuer,Philipp Jurmeister,Michael Bockmayr,Jan Budczies,Jochen Lennerz,Johannes Eschrich,Daniel Kazdal,Peter Schirmacher,Alex H Wagner,Frank Tacke,David Capper,Klaus-Robert Müller,Frederick Klauschen

DOI: https://doi.org/10.1016/j.semcancer.2021.02.011

Abstract:The complexity of diagnostic (surgical) pathology has increased substantially over the last decades with respect to histomorphological and molecular profiling. Pathology has steadily expanded its role in tumor diagnostics and beyond from disease entity identification via prognosis estimation to precision therapy prediction. It is therefore not surprising that pathology is among the disciplines in medicine with high expectations in the application of artificial intelligence (AI) or machine learning approaches given their capabilities to analyze complex data in a quantitative and standardized manner to further enhance scope and precision of diagnostics. While an obvious application is the analysis of histological images, recent applications for the analysis of molecular profiling data from different sources and clinical data support the notion that AI will enhance both histopathology and molecular pathology in the future. At the same time, current literature should not be misunderstood in a way that pathologists will likely be replaced by AI applications in the foreseeable future. Although AI will transform pathology in the coming years, recent studies reporting AI algorithms to diagnose cancer or predict certain molecular properties deal with relatively simple diagnostic problems that fall short of the diagnostic complexity pathologists face in clinical routine. Here, we review the pertinent literature of AI methods and their applications to pathology, and put the current achievements and what can be expected in the future in the context of the requirements for research and routine diagnostics.
Pros and cons of artificial intelligence implementation in diagnostic pathology

Paul J van Diest,Rachel N Flach,Carmen van Dooijeweert,Seher Makineli,Gerben E Breimer,Nikolas Stathonikos,Paul Pham,Tri Q Nguyen,Mitko Veta

DOI: https://doi.org/10.1111/his.15153

2024-03-04

Histopathology

Abstract:Companies are introducing algorithms to the market, and questions arise whether the pathology community is ready for artificial intelligence (AI) integration in routine practices. However, concerns regarding AI use in pathology are emerging. This review discusses the pros and cons of introducing AI in diagnostic pathology. The rapid introduction of digital pathology has greatly facilitated development of artificial intelligence (AI) models in pathology that have shown great promise in assisting morphological diagnostics and quantitation of therapeutic targets. We are now at a tipping point where companies have started to bring algorithms to the market, and questions arise whether the pathology community is ready to implement AI in routine workflow. However, concerns also arise about the use of AI in pathology. This article reviews the pros and cons of introducing AI in diagnostic pathology.

pathology,cell biology
Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects

Gregory Verghese,Jochen K Lennerz,Danny Ruta,Wen Ng,Selvam Thavaraj,Kalliopi P Siziopikou,Threnesan Naidoo,Swapnil Rane,Roberto Salgado,Sarah E Pinder,Anita Grigoriadis

DOI: https://doi.org/10.1002/path.6163

2023-08-16

The Journal of Pathology

Abstract:Computational pathology refers to applying deep learning techniques and algorithms to analyse and interpret histopathology images. Advances in artificial intelligence (AI) have led to an explosion in innovation in computational pathology, ranging from the prospect of automation of routine diagnostic tasks to the discovery of new prognostic and predictive biomarkers from tissue morphology. Despite the promising potential of computational pathology, its integration in clinical settings has been limited by a range of obstacles including operational, technical, regulatory, ethical, financial, and cultural challenges. Here, we focus on the pathologists' perspective of computational pathology: we map its current translational research landscape, evaluate its clinical utility, and address the more common challenges slowing clinical adoption and implementation. We conclude by describing contemporary approaches to drive forward these techniques. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

oncology,pathology
Artificial intelligence (AI) in medicine, current applications and future role with special emphasis on its potential and promise in pathology: present and future impact, obstacles including costs and acceptance among pathologists, practical and philosophical considerations. A comprehensive review

Zubair Ahmad,Shabina Rahim,Maha Zubair,Jamshid Abdul-Ghafar

DOI: https://doi.org/10.1186/s13000-021-01085-4

2021-03-17

Diagnostic Pathology

Abstract:Abstract Background The role of Artificial intelligence (AI) which is defined as the ability of computers to perform tasks that normally require human intelligence is constantly expanding. Medicine was slow to embrace AI. However, the role of AI in medicine is rapidly expanding and promises to revolutionize patient care in the coming years. In addition, it has the ability to democratize high level medical care and make it accessible to all parts of the world. Main text Among specialties of medicine, some like radiology were relatively quick to adopt AI whereas others especially pathology (and surgical pathology in particular) are only just beginning to utilize AI. AI promises to play a major role in accurate diagnosis, prognosis and treatment of cancers. In this paper, the general principles of AI are defined first followed by a detailed discussion of its current role in medicine. In the second half of this comprehensive review, the current and future role of AI in surgical pathology is discussed in detail including an account of the practical difficulties involved and the fear of pathologists of being replaced by computer algorithms. A number of recent studies which demonstrate the usefulness of AI in the practice of surgical pathology are highlighted. Conclusion AI has the potential to transform the practice of surgical pathology by ensuring rapid and accurate results and enabling pathologists to focus on higher level diagnostic and consultative tasks such as integrating molecular, morphologic and clinical information to make accurate diagnosis in difficult cases, determine prognosis objectively and in this way contribute to personalized care.

pathology
Computational pathology: an evolving concept

Ioannis Prassas,Blaise Clarke,Timothy Youssef,Juliana Phlamon,Lampros Dimitrakopoulos,Andrew Rofaeil,George M. Yousef

DOI: https://doi.org/10.1515/cclm-2023-1124

2024-04-24

Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract:The initial enthusiasm about computational pathology (CP) and artificial intelligence (AI) was that they will replace pathologists entirely on the way to fully automated diagnostics. It is becoming clear that currently this is not the immediate model to pursue. On top of the legal and regulatory complexities surrounding its implementation, the majority of tested machine learning (ML)-based predictive algorithms do not display the exquisite performance needed to render them unequivocal, standalone decision makers for matters with direct implications to human health. We are thus moving into a different model of "computer-assisted diagnostics", where AI is there to provide support, rather than replacing, the pathologist. Herein we focus on the practical aspects of CP, from a pathologist perspective. There is a wide range of potential applications where CP can enhance precision of pathology diagnosis, tailor prognostic and predictive information, as well as save time. There are, however, a number of potential limitations for CP that currently hinder their wider adoption in the clinical setting. We address the key necessary steps towards clinical implementation of computational pathology, discuss the significant obstacles that hinders its adoption in the clinical context and summarize some proposed solutions. We conclude that the advancement of CP in the clinic is a promising resource-intensive endeavour that requires broad and inclusive collaborations between academia, industry, and regulatory bodies.

medical laboratory technology
Artificial intelligence in diagnostic pathology

Saba Shafi,Anil V Parwani,Anil V. Parwani

DOI: https://doi.org/10.1186/s13000-023-01375-z

2023-10-04

Diagnostic Pathology

Abstract:Digital pathology (DP) is being increasingly employed in cancer diagnostics, providing additional tools for faster, higher-quality, accurate diagnosis. The practice of diagnostic pathology has gone through a staggering transformation wherein new tools such as digital imaging, advanced artificial intelligence (AI) algorithms, and computer-aided diagnostic techniques are being used for assisting, augmenting and empowering the computational histopathology and AI-enabled diagnostics. This is paving the way for advancement in precision medicine in cancer. Automated whole slide imaging (WSI) scanners are now rendering diagnostic quality, high-resolution images of entire glass slides and combining these images with innovative digital pathology tools is making it possible to integrate imaging into all aspects of pathology reporting including anatomical, clinical, and molecular pathology. The recent approvals of WSI scanners for primary diagnosis by the FDA as well as the approval of prostate AI algorithm has paved the way for starting to incorporate this exciting technology for use in primary diagnosis. AI tools can provide a unique platform for innovations and advances in anatomical and clinical pathology workflows. In this review, we describe the milestones and landmark trials in the use of AI in clinical pathology with emphasis on future directions.

pathology
Artificial Intelligence for Digital and Computational Pathology

Andrew H. Song,Guillaume Jaume,Drew F.K. Williamson,Ming Y. Lu,Anurag Vaidya,Tiffany R. Miller,Faisal Mahmood

DOI: https://doi.org/10.48550/arXiv.2401.06148

2023-12-13

Image and Video Processing

Abstract:Advances in digitizing tissue slides and the fast-paced progress in artificial intelligence, including deep learning, have boosted the field of computational pathology. This field holds tremendous potential to automate clinical diagnosis, predict patient prognosis and response to therapy, and discover new morphological biomarkers from tissue images. Some of these artificial intelligence-based systems are now getting approved to assist clinical diagnosis; however, technical barriers remain for their widespread clinical adoption and integration as a research tool. This Review consolidates recent methodological advances in computational pathology for predicting clinical end points in whole-slide images and highlights how these developments enable the automation of clinical practice and the discovery of new biomarkers. We then provide future perspectives as the field expands into a broader range of clinical and research tasks with increasingly diverse modalities of clinical data.
AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?

Didem Cifci,Gregory P. Veldhuizen,Sebastian Foersch,Jakob Nikolas Kather

DOI: https://doi.org/10.1146/annurev-cancerbio-061521-092038

2023-04-12

Annual Review of Cancer Biology

Abstract:Histopathology plays a fundamental role in the diagnosis and subtyping of solid tumors and has become a cornerstone of modern precision oncology. Histopathological evaluation is typically performed manually by expert pathologists due to the complexity of visual data. However, in the last ten years, new artificial intelligence (AI) methods have made it possible to train computers to perform visual tasks with high performance, reaching similar levels as experts in some applications. In cancer histopathology, these AI tools could help automate repetitive tasks, making more efficient use of pathologists’ time. In research studies, AI methods have been shown to have an astounding ability to predict genetic alterations and identify prognostic and predictive biomarkers directly from routine tissue slides. Here, we give an overview of these recent applications of AI in computational pathology, focusing on new tools for cancer research that could be pivotal in identifying clinical biomarkers for better treatment decisions.

oncology
Current Developments of Artificial Intelligence in Digital Pathology and Its Future Clinical Applications in Gastrointestinal Cancers

Alex Ngai Nick Wong,Zebang He,Ka Long Leung,Curtis Chun Kit To,Chun Yin Wong,Sze Chuen Cesar Wong,Jung Sun Yoo,Cheong Kin Ronald Chan,Angela Zaneta Chan,Maribel D. Lacambra,Martin Ho Yin Yeung

DOI: https://doi.org/10.3390/cancers14153780

2022-08-04

Cancers

Abstract:The implementation of DP will revolutionize current practice by providing pathologists with additional tools and algorithms to improve workflow. Furthermore, DP will open up opportunities for development of AI-based tools for more precise and reproducible diagnosis through computational pathology. One of the key features of AI is its capability to generate perceptions and recognize patterns beyond the human senses. Thus, the incorporation of AI into DP can reveal additional morphological features and information. At the current rate of AI development and adoption of DP, the interest in computational pathology is expected to rise in tandem. There have already been promising developments related to AI-based solutions in prostate cancer detection; however, in the GI tract, development of more sophisticated algorithms is required to facilitate histological assessment of GI specimens for early and accurate diagnosis. In this review, we aim to provide an overview of the current histological practices in AP laboratories with respect to challenges faced in image preprocessing, present the existing AI-based algorithms, discuss their limitations and present clinical insight with respect to the application of AI in early detection and diagnosis of GI cancer.

oncology
Implementation of Digital Pathology and Artificial Intelligence in Routine Pathology Practice

David Y Zhang,Arsha Venkat,Hamdi Khasawneh,Rasoul Sali,Valerio Zhang,Zhiheng Pei

DOI: https://doi.org/10.1016/j.labinv.2024.102111

2024-07-23

Abstract:The advent of affordable technology has significantly influenced the practice of digital pathology, leading to its growing adoption within the pathology community. This review article aimed to outline the latest developments in digital pathology, the cutting-edge advancements in artificial intelligence (AI) applications within this field, and the pertinent United States regulatory frameworks. The content is based on a thorough analysis of original research articles and official United States Federal guidelines. Findings from our review indicate that several Food and Drug Administration-approved digital scanners and image management systems are establishing a solid foundation for the seamless integration of advanced technologies into everyday pathology workflows, which may reduce device and operational costs in the future. AI is particularly transforming the way morphologic diagnoses are automated, notably in cancers like prostate and colorectal, within screening initiatives, albeit challenges such as data privacy issues and algorithmic biases remain. The regulatory environment, shaped by standards from the Food and Drug Administration, Centers for Medicare & Medicaid Services/Clinical Laboratory Improvement Amendments, and College of American Pathologists, is evolving to accommodate these innovations while ensuring safety and reliability. Centers for Medicare & Medicaid Services/Clinical Laboratory Improvement Amendments have issued policies to allow pathologists to review and render diagnoses using digital pathology remotely. Moreover, the introduction of new digital pathology Current Procedural Terminology codes designed to complement existing pathology Current Procedural Terminology codes is facilitating reimbursement processes. Overall, these advancements are heralding a new era in pathology that promises enhanced diagnostic precision and efficiency through digital and AI technologies, potentially improving patient care as well as bolstering educational and research activities.
Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology

Oliver C Turner,Famke Aeffner,Dinesh S Bangari,Wanda High,Brian Knight,Tom Forest,Brieuc Cossic,Lauren E Himmel,Daniel G Rudmann,Bhupinder Bawa,Anantharaman Muthuswamy,Olulanu H Aina,Elijah F Edmondson,Chandrassegar Saravanan,Danielle L Brown,Tobias Sing,Manu M Sebastian

DOI: https://doi.org/10.1177/0192623319881401

Abstract:Toxicologic pathology is transitioning from analog to digital methods. This transition seems inevitable due to a host of ongoing social and medical technological forces. Of these, artificial intelligence (AI) and in particular machine learning (ML) are globally disruptive, rapidly growing sectors of technology whose impact on the long-established field of histopathology is quickly being realized. The development of increasing numbers of algorithms, peering ever deeper into the histopathological space, has demonstrated to the scientific community that AI pathology platforms are now poised to truly impact the future of precision and personalized medicine. However, as with all great technological advances, there are implementation and adoption challenges. This review aims to define common and relevant AI and ML terminology, describe data generation and interpretation, outline current and potential future business cases, discuss validation and regulatory hurdles, and most importantly, propose how overcoming the challenges of this burgeoning technology may shape toxicologic pathology for years to come, enabling pathologists to contribute even more effectively to answering scientific questions and solving global health issues. [Box: see text].
The emerging role of artificial intelligence in neuropathology: where are we and where do we want to go?

Giuseppe Broggi,Manuel Mazzucchelli,Serena Salzano,Giuseppe Maria Vincenzo Barbagallo,Francesco Certo,Magda Zanelli,Andrea Palicelli,Maurizio Zizzo,Nektarios Koufopoulos,Gaetano Magro,Rosario Caltabiano

DOI: https://doi.org/10.1016/j.prp.2024.155671

IF: 3.309

2024-10-26

Pathology - Research and Practice

Abstract:The field of neuropathology, a subspecialty of pathology which studies the diseases affecting the nervous system, is experiencing significant changes due to advancements in artificial intelligence (AI). Traditionally reliant on histological methods and clinical correlations, neuropathology is now experiencing a revolution due to the development of AI technologies like machine learning (ML) and deep learning (DL). These technologies enhance diagnostic accuracy, optimize workflows, and enable personalized treatment strategies. AI algorithms excel at analyzing histopathological images, often revealing subtle morphological changes missed by conventional methods. For example, deep learning models applied to digital pathology can effectively differentiate tumor grades and detect rare pathologies, leading to earlier and more precise diagnoses. Progress in neuroimaging is another helpful tool of AI, as enhanced analysis of MRI and CT scans supports early detection of neurodegenerative diseases. By identifying biomarkers and progression patterns, AI aids in timely therapeutic interventions, potentially slowing disease progression. In molecular pathology, AI's ability to analyze complex genomic data helps uncover the genetic and molecular basis of neuropathological conditions, facilitating personalized treatment plans. AI-driven automation streamlines routine diagnostic tasks, allowing pathologists to focus on complex cases, especially in settings with limited resources. This review explores AI's integration into neuropathology, highlighting its current applications, benefits, challenges, and future directions.

pathology
Emerging role of deep learning-based artificial intelligence in tumor pathology

Yahui Jiang,Meng Yang,Shuhao Wang,Xiangchun Li,Yan Sun

DOI: https://doi.org/10.1002/cac2.12012

IF: 15.2825

2020-01-01

Cancer Communications

Abstract:The development of digital pathology and progression of state-of-the-art algorithms for computer vision have led to increasing interest in the use of artificial intelligence (AI), especially deep learning (DL)-based AI, in tumor pathology. The DL-based algorithms have been developed to conduct all kinds of work involved in tumor pathology, including tumor diagnosis, subtyping, grading, staging, and prognostic prediction, as well as the identification of pathological features, biomarkers and genetic changes. The applications of AI in pathology not only contribute to improve diagnostic accuracy and objectivity but also reduce the workload of pathologists and subsequently enable them to spend additional time on high-level decision-making tasks. In addition, AI is useful for pathologists to meet the requirements of precision oncology. However, there are still some challenges relating to the implementation of AI, including the issues of algorithm validation and interpretability, computing systems, the unbelieving attitude of pathologists, clinicians and patients, as well as regulators and reimbursements. Herein, we present an overview on how AI-based approaches could be integrated into the workflow of pathologists and discuss the challenges and perspectives of the implementation of AI in tumor pathology.
Emerging Role of Deep Learning‐based Artificial Intelligence in Tumor Pathology

Yahui Jiang,Meng Yang,Shuhao Wang,Xiangchun Li,Yan Sun

DOI: https://doi.org/10.1002/cac2.12012

IF: 15.2825

2020-01-01

Cancer Communications

Abstract:The development of digital pathology and progression of state‐of‐the‐art algorithms for computer vision have led to increasing interest in the use of artificial intelligence (AI), especially deep learning (DL)‐based AI, in tumor pathology. The DL‐based algorithms have been developed to conduct all kinds of work involved in tumor pathology, including tumor diagnosis, subtyping, grading, staging, and prognostic prediction, as well as the identification of pathological features, biomarkers and genetic changes. The applications of AI in pathology not only contribute to improve diagnostic accuracy and objectivity but also reduce the workload of pathologists and subsequently enable them to spend additional time on high‐level decision‐making tasks. In addition, AI is useful for pathologists to meet the requirements of precision oncology. However, there are still some challenges relating to the implementation of AI, including the issues of algorithm validation and interpretability, computing systems, the unbelieving attitude of pathologists, clinicians and patients, as well as regulators and reimbursements. Herein, we present an overview on how AI‐based approaches could be integrated into the workflow of pathologists and discuss the challenges and perspectives of the implementation of AI in tumor pathology.
Advancements in computer vision and pathology: Unraveling the potential of artificial intelligence for precision diagnosis and beyond

Justin Chang,Bryce Hatfield

DOI: https://doi.org/10.1016/bs.acr.2024.05.006

Abstract:The integration of computer vision into pathology through slide digitalization represents a transformative leap in the field's evolution. Traditional pathology methods, while reliable, are often time-consuming and susceptible to intra- and interobserver variability. In contrast, computer vision, empowered by artificial intelligence (AI) and machine learning (ML), promises revolutionary changes, offering consistent, reproducible, and objective results with ever-increasing speed and scalability. The applications of advanced algorithms and deep learning architectures like CNNs and U-Nets augment pathologists' diagnostic capabilities, opening new frontiers in automated image analysis. As these technologies mature and integrate into digital pathology workflows, they are poised to provide deeper insights into disease processes, quantify and standardize biomarkers, enhance patient outcomes, and automate routine tasks, reducing pathologists' workload. However, this transformative force calls for cross-disciplinary collaboration between pathologists, computer scientists, and industry innovators to drive research and development. While acknowledging its potential, this chapter addresses the limitations of AI in pathology, encompassing technical, practical, and ethical considerations during development and implementation.
Observations on radiation exposure to the wrist during radionuclide administration as measured and reported using film-badge techniques.

A. Rudavsky

Health Physics

Abstract:
The ethical challenges of artificial intelligence‐driven digital pathology

Francis McKay,Bethany J Williams,Graham Prestwich,Daljeet Bansal,Nina Hallowell,Darren Treanor

DOI: https://doi.org/10.1002/cjp2.263

2022-02-17

THE JOURNAL OF PATHOLOGY: CLINICAL RESEARCH

Abstract:Digital pathology - the digitalisation of clinical histopathology services through the scanning and storage of pathology slides - has opened up new possibilities for health care in recent years, particularly in the opportunities it brings for artificial intelligence (AI)-driven research. Recognising, however, that there is little scholarly debate on the ethics of digital pathology when used for AI research, this paper summarises what it sees as four key ethical issues to consider when deploying AI infrastructures in pathology, namely, privacy, choice, equity, and trust. The themes are inspired from the authors' experience grappling with the challenge of deploying an ethical digital pathology infrastructure to support AI research as part of the National Pathology Imaging Cooperative (NPIC), a collaborative of universities, hospital trusts, and industry partners largely located across the North of England. Though focusing on the UK case, internationally, few pathology departments have gone fully digital, and so the themes developed here offer a heuristic for ethical reflection for other departments currently making a similar transition or planning to do so in the future. We conclude by promoting the need for robust public governance mechanisms in AI-driven digital pathology.

Comparison of root canal debridement using hand, sonic, and ultrasonic techniques.

AI in Pathology: What could possibly go wrong?

Shelf-stable and safe intermediate-moisture meat products using hurdle technology.

Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling

Pros and cons of artificial intelligence implementation in diagnostic pathology

Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects

Artificial intelligence (AI) in medicine, current applications and future role with special emphasis on its potential and promise in pathology: present and future impact, obstacles including costs and acceptance among pathologists, practical and philosophical considerations. A comprehensive review

Computational pathology: an evolving concept

Artificial intelligence in diagnostic pathology

Artificial Intelligence for Digital and Computational Pathology

AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?

Current Developments of Artificial Intelligence in Digital Pathology and Its Future Clinical Applications in Gastrointestinal Cancers

Implementation of Digital Pathology and Artificial Intelligence in Routine Pathology Practice

Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology

The emerging role of artificial intelligence in neuropathology: where are we and where do we want to go?

Emerging role of deep learning-based artificial intelligence in tumor pathology

Emerging Role of Deep Learning‐based Artificial Intelligence in Tumor Pathology

Advancements in computer vision and pathology: Unraveling the potential of artificial intelligence for precision diagnosis and beyond

Observations on radiation exposure to the wrist during radionuclide administration as measured and reported using film-badge techniques.

The ethical challenges of artificial intelligence‐driven digital pathology